Moritz Gröger

1.2k total citations
52 papers, 816 citations indexed

About

Moritz Gröger is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Moritz Gröger has authored 52 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology and Allergy, 32 papers in Physiology and 18 papers in Dermatology. Recurrent topics in Moritz Gröger's work include Allergic Rhinitis and Sensitization (42 papers), Asthma and respiratory diseases (32 papers) and Food Allergy and Anaphylaxis Research (11 papers). Moritz Gröger is often cited by papers focused on Allergic Rhinitis and Sensitization (42 papers), Asthma and respiratory diseases (32 papers) and Food Allergy and Anaphylaxis Research (11 papers). Moritz Gröger collaborates with scholars based in Germany, Austria and United States. Moritz Gröger's co-authors include Sven Becker, Matthias Krämer, Nikolaus Plesnila, Martin Canis, Katharina Eder, Christine A. Klemens, Changlian Zhu, Klas Blomgren, Carsten Culmsee and Michael A. Moskowitz and has published in prestigious journals such as Scientific Reports, Brain Research and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Moritz Gröger

45 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moritz Gröger Germany 15 425 340 150 146 119 52 816
Janice A. Layhadi United Kingdom 21 747 1.8× 696 2.0× 134 0.9× 335 2.3× 34 0.3× 52 1.3k
Marko Vukovic United States 6 164 0.4× 249 0.7× 108 0.7× 13 0.1× 158 1.3× 6 650
Bengü Çobanoğlu Türkiye 12 57 0.1× 100 0.3× 96 0.6× 38 0.3× 25 0.2× 57 432
David Hollander United States 26 169 0.4× 39 0.1× 173 1.2× 89 0.6× 3 0.0× 88 1.8k
Ruud A.J. Warringa Netherlands 12 213 0.5× 382 1.1× 57 0.4× 92 0.6× 8 0.1× 15 610
R.A. Sabroe United Kingdom 24 308 0.7× 157 0.5× 90 0.6× 570 3.9× 4 0.0× 49 2.2k
Rachel Baum United States 12 54 0.1× 281 0.8× 368 2.5× 8 0.1× 30 0.3× 23 823
Yehai Liu China 14 26 0.1× 50 0.1× 317 2.1× 10 0.1× 71 0.6× 78 688
Hiroko Yamagami United States 19 137 0.3× 132 0.4× 131 0.9× 243 1.7× 34 1.2k
S.-H. Park South Korea 12 15 0.0× 106 0.3× 223 1.5× 15 0.1× 11 0.1× 32 792

Countries citing papers authored by Moritz Gröger

Since Specialization
Citations

This map shows the geographic impact of Moritz Gröger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Gröger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Gröger more than expected).

Fields of papers citing papers by Moritz Gröger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz Gröger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Gröger. The network helps show where Moritz Gröger may publish in the future.

Co-authorship network of co-authors of Moritz Gröger

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz Gröger. A scholar is included among the top collaborators of Moritz Gröger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz Gröger. Moritz Gröger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hagemann, Jan, Ludger Klimek, Moritz Gröger, et al.. (2025). Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in Germany. Rhinology Journal. 0(0). 0–0.
2.
Nowak, Dennis, Moritz Gröger, Eva Oppel, et al.. (2025). Association of grass pollen concentration and physical symptoms as well as impairments in day-to-day life in pollen allergy patients. Scientific Reports. 15(1). 18685–18685.
3.
Haubner, Frank, et al.. (2024). The use of biologics in patients suffering from chronic rhinosinusitis with nasal polyps – a 4-year real life observation. European Archives of Oto-Rhino-Laryngology. 281(11). 5773–5782. 6 indexed citations
4.
Förster‐Ruhrmann, Ulrike, Heidi Olze, Sven Becker, et al.. (2024). Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years. Allergy. 79(11). 3108–3117. 5 indexed citations
5.
Bertlich, Mattis, et al.. (2024). Serological Cross-Reactivity of Various <i>Aspergillus</i> spp. with <i>Aspergillus fumigatus</i>: A Diagnostic Blind Spot. International Archives of Allergy and Immunology. 185(8). 767–774.
6.
Klimek, Ludger, Wolfgang Wehrmann, Randolf Brehler, et al.. (2024). Physician’s perspectives on skin prick testing and allergy diagnostics in Germany. Allergo Journal International. 33(5). 159–164.
7.
Förster‐Ruhrmann, Ulrike, Ludger Klimek, Kai Fruth, et al.. (2024). Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease“ und stattgehabter ASS‑Desaktivierung. HNO. 72(7). 473–483. 4 indexed citations
8.
Schreiber, Fabian, Dennis Nowak, Moritz Gröger, et al.. (2023). Conception and pilot testing of a self-management health application for patients with pollen-related allergic rhinitis and allergic asthma-the APOLLO app. Scientific Reports. 13(1). 21568–21568. 5 indexed citations
9.
Klimek, Ludger, Christoph Bergmann, Jan Hagemann, et al.. (2023). Neuroimmunologie der allergischen Rhinitis Teil 2. HNO. 71(6). 413–421. 5 indexed citations
10.
Gröger, Moritz, et al.. (2023). Neonatal hearing screening - does failure in TEOAE screening matter when the AABR test is passed?. European Archives of Oto-Rhino-Laryngology. 281(3). 1273–1283.
11.
Klimek, Ludger, Christoph Bergmann, Jan Hagemann, et al.. (2023). Neuroimmunologie der allergischen Rhinitis. HNO. 71(5). 337–346. 4 indexed citations
12.
Straßen, Ulrich, Murat Baş, Magdalena A. Wirth, et al.. (2022). Efficacy of human C1 esterase inhibitor concentrate for treatment of ACE-inhibitor induced angioedema. The American Journal of Emergency Medicine. 64. 121–128. 5 indexed citations
13.
Hölzer, Martin, et al.. (2021). How reliable is anamnestic data in predicting the clinical relevance of house dust mite sensitization?. European Archives of Oto-Rhino-Laryngology. 279(2). 801–810. 6 indexed citations
14.
Eder, Katharina, et al.. (2018). Component resolved analysis of ash pollen allergy in Bavaria. Allergy Asthma and Clinical Immunology. 14(1). 76–76. 2 indexed citations
15.
Braun, Thomas, et al.. (2016). Clinical Relevance of IgE to Profilin and/or Polcalcin in Pollen-Sensitized Patients. International Archives of Allergy and Immunology. 169(2). 101–107. 21 indexed citations
16.
Becker, Sven, et al.. (2015). Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa. European Archives of Oto-Rhino-Laryngology. 273(6). 1469–1475. 24 indexed citations
17.
Klemens, Christine A., et al.. (2015). Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis. Allergy Asthma and Clinical Immunology. 11(1). 26–26. 58 indexed citations
18.
Gröger, Moritz & Nikolaus Plesnila. (2014). The neuroprotective effect of 17β-estradiol is independent of its antioxidative properties. Brain Research. 1589. 61–67. 6 indexed citations
19.
Gröger, Moritz, et al.. (2013). Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases. European Archives of Oto-Rhino-Laryngology. 270(10). 2667–2676. 31 indexed citations
20.
Burggraf, Dorothe, Martin Liebetrau, Nathalie Wunderlich, et al.. (2006). Influence of the duration of ischemia and reperfusion on infarct volume and microvascular damage in mice. Neurological Research. 28(2). 200–205. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janice A. Layhadi Breakdown of academic impact, for papers by Marko Vukovic Breakdown of academic impact, for papers by Bengü Çobanoğlu Breakdown of academic impact, for papers by David Hollander Breakdown of academic impact, for papers by Ruud A.J. Warringa Breakdown of academic impact, for papers by R.A. Sabroe Breakdown of academic impact, for papers by Rachel Baum Breakdown of academic impact, for papers by Yehai Liu Breakdown of academic impact, for papers by Hiroko Yamagami Breakdown of academic impact, for papers by S.-H. Park
Rankless by CCL
2026